Nanox completes acquisition of Zebra Medical Vision
Concurrently, Nanox completed two further strategic acquisitions, securing USARAD and MDWEB.
Monitoring
The pandemic has highlighted the importance of telemedicine
The Covid-19 pandemic has brought forward the need for advancements in telemedicine, which has led...
Nutriband to manufacture Diomics’ Covid-19 transdermal test
In 24 to 36 hours, the test can identify if an individual has developed a...
MYND forms diagnostic subsidiary to market tests for psychiatric disorders
MYND Diagnostics will carry out trials to detect a marker for diagnosing and monitoring depression...
UAB team to trial FDA-cleared device for traumatic brain injury monitoring
Infrascanner uses near-infrared spectroscopy to detect intracranial hematomas based on differential light absorption.
Rates of ransomware attacks continue to rise, impacting mortality rates
Ransomware attacks in the medical industry are compromising patient safety and care and have contributed to increased mortality rates.
Study finds Masimo’s EMMA device effective in preterm infants
The proportion of preterm infants with appropriate PaCO₂ was higher in the EMMA arm compared to the control.
NeuroOne secures 510(k) clearance from US FDA for Evo sEEG Electrode
The clearance will enable NeuroOne to market Evo sEEG Electrode for uses of less than 24 hours.
Zimmer and Canary’s smart knee implant receives FDA clearance
Persona IQ offers objective data to monitor post-operative progress in total knee replacement surgery patients.
Abbott’s CardioMEMS system lowers mortality in heart failure patients
Data adjusted for the Covid-19 impact showed that the device led to a significant decrease in heart failure hospitalisations.
Hyperfine’s MRI device offers key data for stroke treatment, study finds
The portable MRI system is cheaper compared to conventional MRI technologies and requires minimal training for usage.
